AxoSim touts results of nerve-on-a-chip study

A new study of AxoSim’s Nerve-on-a-Chip technology shows that the platform accurately provides key physiological readouts that could help speed the development of drugs to treat neurological disorders. The study also shows that Nerve-on-a-Chip technology is the first all-human in vitro model that can measure critical factors that were formerly only available using live animal models. These include robust axonal outgrowth, myelination of human stem cell-derived neurons by primary human Schwann cells, and evaluation of nerve conduction velocity, according to the New Orleans-based company. Get the full story on our sister site, Drug Delivery Business.
Source: Mass Device - Category: Medical Devices Authors: Tags: Blog Featured Neurological Research & Development Stem Cells axosim Source Type: news